1. Home
  2. XERS vs YALA Comparison

XERS vs YALA Comparison

Compare XERS & YALA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XERS
  • YALA
  • Stock Information
  • Founded
  • XERS 2005
  • YALA 2016
  • Country
  • XERS United States
  • YALA United Arab Emirates
  • Employees
  • XERS N/A
  • YALA N/A
  • Industry
  • XERS Biotechnology: Pharmaceutical Preparations
  • YALA Computer Software: Programming Data Processing
  • Sector
  • XERS Health Care
  • YALA Technology
  • Exchange
  • XERS Nasdaq
  • YALA Nasdaq
  • Market Cap
  • XERS 1.3B
  • YALA 1.2B
  • IPO Year
  • XERS 2018
  • YALA 2020
  • Fundamental
  • Price
  • XERS $7.64
  • YALA $7.54
  • Analyst Decision
  • XERS Strong Buy
  • YALA
  • Analyst Count
  • XERS 7
  • YALA 0
  • Target Price
  • XERS $9.43
  • YALA N/A
  • AVG Volume (30 Days)
  • XERS 3.0M
  • YALA 394.6K
  • Earning Date
  • XERS 11-06-2025
  • YALA 11-10-2025
  • Dividend Yield
  • XERS N/A
  • YALA N/A
  • EPS Growth
  • XERS N/A
  • YALA 14.19
  • EPS
  • XERS N/A
  • YALA 0.81
  • Revenue
  • XERS $266,137,000.00
  • YALA $348,190,638.00
  • Revenue This Year
  • XERS $43.89
  • YALA $3.95
  • Revenue Next Year
  • XERS $20.40
  • YALA $10.18
  • P/E Ratio
  • XERS N/A
  • YALA $8.89
  • Revenue Growth
  • XERS 42.05
  • YALA 6.79
  • 52 Week Low
  • XERS $2.82
  • YALA $3.83
  • 52 Week High
  • XERS $10.08
  • YALA $9.29
  • Technical
  • Relative Strength Index (RSI)
  • XERS 36.31
  • YALA 58.04
  • Support Level
  • XERS $7.00
  • YALA $6.99
  • Resistance Level
  • XERS $10.08
  • YALA $7.83
  • Average True Range (ATR)
  • XERS 0.53
  • YALA 0.26
  • MACD
  • XERS -0.26
  • YALA 0.04
  • Stochastic Oscillator
  • XERS 23.38
  • YALA 78.57

About XERS Xeris Biopharma Holdings Inc.

Xeris Biopharma Holdings Inc is a biopharmaceutical company focused on developing and commercializing therapies for people with chronic endocrine and neurological diseases in the United States. It offer Recorlev for the treatment of Cushing's syndrome, Gvoke for the treatment of severe hypoglycemia, and Keveyis for the treatment of Primary Periodic Paralysis (PPP).

About YALA Yalla Group Limited each representing one

Yalla Group Ltd is a MENA-based online social networking and gaming company. It operates two flagship mobile applications, Yalla, a voice-centric group chat platform, and Yalla Ludo, a casual gaming application featuring online versions of board games popular in MENA, with in-game voice chat and localized majlis functions. The Group has one operating segment, which is the social networking and entertainment platform.

Share on Social Networks: